Alex Minter, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Brachytherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Radiation Therapy Targeted Therapy
Dr. Alex Minter graduated from the University of Alabama School of Medicine and later completed his residency program at the University of Alabama Medical Center. He also did a fellowship at the National Capital Consortium. He is specialized in Medical Oncology and board certified in Internal Medicine, Hematology and Oncology. Dr. Minter has been in practice for more than 11 years and is affiliated with the Riverview Hospital. During his career, he has also contributed to 7 research publications.
University of Alabama School of Medicine
Medical School
University of Alabama Medical Center
Residency
National Capital Consortium
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.
Korde, N.,Carlsten, M.,Lee, M. J.,Minter, A.,Tan, E.,Kwok, M.,Manasanch, E.,Bhutani, M.,Tageja, N.,Roschewski, M.,Zingone, A.,Costello, R.,Mulquin, M.,Zuchlinski, D.,M...; Haematologica. 2014 Mar 25.
See more >>Unusual Late Presentation of Hemophilia A in an Active Duty U.S. Marine Following Open Shoulder Surgery.
Shapiro, B. H.,Minter, A. R.,McDonald, L. S.; Mil Med. 2015 Dec 04.
See more >>Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging.
Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, Linde...; Leuk. Lymphoma. 2016-05-01.
See more >>